Evidence map›Paper›PMID 32613494›Full record

ArticleClinical and experimental nephrology2020

Associations between visceral obesity and renal impairment in health checkup participants: a retrospective cohort study.

Yoshikazu Miyasato, Koji Oba, Shinji Yasuno, Yutaka Matsuyama, Izuru Masuda

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  7. Article
  8. Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yoshikazu MiyasatoDepartment of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Bunkyo-ku, Hongo, Tokyo, 1130033, Japan.
Koji ObaDepartment of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Bunkyo-ku, Hongo, Tokyo, 1130033, Japan. oba@epistat.m.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0001-5468-8988
Shinji YasunoClinical Research Support Center, Jikei University School of Medicine, Tokyo, 1058461, Japan.
Yutaka MatsuyamaDepartment of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Bunkyo-ku, Hongo, Tokyo, 1130033, Japan.
Izuru MasudaTakeda Hospital Medical Examination Center, Kyoto, 6008216, Japan.
The University of Tokyo · JPJikei University School of Medicine · JPTakeda (Japan) · JP

Funding

The University of Tokyo the Leading Initiative for Excellent Young Researchers
6 · The paper itself

Abstract

backgroundObesity is a risk factor for chronic kidney disease. Although body mass index (BMI) or waist circumference is indicators of obesity, actual measurements of visceral fat area (VFA) more accurately reflect the amount of visceral fat. We aimed to determine the most sensitive obesity indicator for predicting renal impairment among VFA, BMI, waist circumference, waist-to-height ratio, and visceral-to-subcutaneous fat ratio (VSR).

methodsSubjects who underwent VFA measurements during health checkups in 2012 were included. Obesity was defined using a separate baseline value for each indicator [VFA (100 cm

resultsAnalysis was performed on 2753 subjects (mean age 50.3 years). The VFA ≥ 100 cm

conclusionVFA is suggested to be the most sensitive obesity indicator for decline in kidney function and new-onset proteinuria.

Indexed as

Abdominal FatAdultBody HeightBody Mass IndexElectric ImpedanceFemaleGlomerular Filtration RateHumansIncidenceKidney DiseasesMaleMiddle AgedObesity, AbdominalOrgan SizePlethysmography, ImpedanceProteinuriaChronic kidney diseaseObesityProteinuriaRenal impairmentVisceral fat area

Identifiers

PMID32613494
OpenAlexW3038285656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.